,address1,address2,city,state,zip,country,phone,fax,website,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,beta,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,lastSplitFactor,lastSplitDate,enterpriseToRevenue,enterpriseToEbitda,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,gmtOffSetMilliseconds,currentPrice,recommendationKey,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,100 North Fairway Drive,Suite 134,Vernon Hills,IL,60061,United States,847-362-8200,847-362-8394,https://www.winstonlabs.com,"Winston Pharmaceuticals, Inc., a pharmaceutical company, discovers, develops, and commercializes therapeutics for pain management. It focuses on pain indications, such as episodic cluster headache, chronic migraine headache, neuropathic pain syndromes, osteo-and rheumatoid arthritis, and pain and inflammation in inflammatory bowel disease, as well as niche indications. Winston Pharmaceuticals, Inc. was formerly known as Winston Laboratories, Inc. and changed its name to Winston Pharmaceuticals, Inc. in November 2008. The company was incorporated in 1998 and is headquartered in Vernon Hills, Illinois.",9,"{'maxAge': 1, 'name': 'Dr. Joel E. Bernstein M.D.', 'age': 79, 'title': 'Founder, CEO, Pres & Director', 'yearBorn': 1943, 'fiscalYear': 2009, 'totalPay': 288900, 'exercisedValue': 0, 'unexercisedValue': 0}",1262217600,86400,4,0.09,0.09,0.09,0.09,0.09,0.09,0.09,0.09,-863.46936,2949,2949,1584,1584,1584,6966801,0.0003,0.294,5.0804095,0.01824,0.01824,0.0,0.0,USD,6289278,-1.70438,77408896,0.0,0.0,0.001,90.0,1262217600,1293753600,1269993600,-2337223,-0.035,1:8,1232064000,4.586,-2.615,PNK,EQUITY,WPHM,WPHM,WINSTON PHARMACEUTICALS INC,"Winston Pharmaceuticals, Inc.",1685971800,America/New_York,EDT,-14400000,0.09,none,677522,0.009,-2405335,0,0.948,1.044,1371307,0.021,-0.58621,-2.04601,-668346,-2714221,-3542726,-0.068,-0.3442,-1.75405,-1.76048,USD,
1,100 North Fairway Drive,Suite 134,Vernon Hills,IL,60061,United States,847-362-8200,847-362-8394,https://www.winstonlabs.com,"Winston Pharmaceuticals, Inc., a pharmaceutical company, discovers, develops, and commercializes therapeutics for pain management. It focuses on pain indications, such as episodic cluster headache, chronic migraine headache, neuropathic pain syndromes, osteo-and rheumatoid arthritis, and pain and inflammation in inflammatory bowel disease, as well as niche indications. Winston Pharmaceuticals, Inc. was formerly known as Winston Laboratories, Inc. and changed its name to Winston Pharmaceuticals, Inc. in November 2008. The company was incorporated in 1998 and is headquartered in Vernon Hills, Illinois.",9,"{'maxAge': 1, 'name': 'Mr. Barry R. Hollingsworth CPA, CFA', 'age': 57, 'title': 'Chief Financial Officer', 'yearBorn': 1965, 'exercisedValue': 0, 'unexercisedValue': 0}",1262217600,86400,4,0.09,0.09,0.09,0.09,0.09,0.09,0.09,0.09,-863.46936,2949,2949,1584,1584,1584,6966801,0.0003,0.294,5.0804095,0.01824,0.01824,0.0,0.0,USD,6289278,-1.70438,77408896,0.0,0.0,0.001,90.0,1262217600,1293753600,1269993600,-2337223,-0.035,1:8,1232064000,4.586,-2.615,PNK,EQUITY,WPHM,WPHM,WINSTON PHARMACEUTICALS INC,"Winston Pharmaceuticals, Inc.",1685971800,America/New_York,EDT,-14400000,0.09,none,677522,0.009,-2405335,0,0.948,1.044,1371307,0.021,-0.58621,-2.04601,-668346,-2714221,-3542726,-0.068,-0.3442,-1.75405,-1.76048,USD,
2,100 North Fairway Drive,Suite 134,Vernon Hills,IL,60061,United States,847-362-8200,847-362-8394,https://www.winstonlabs.com,"Winston Pharmaceuticals, Inc., a pharmaceutical company, discovers, develops, and commercializes therapeutics for pain management. It focuses on pain indications, such as episodic cluster headache, chronic migraine headache, neuropathic pain syndromes, osteo-and rheumatoid arthritis, and pain and inflammation in inflammatory bowel disease, as well as niche indications. Winston Pharmaceuticals, Inc. was formerly known as Winston Laboratories, Inc. and changed its name to Winston Pharmaceuticals, Inc. in November 2008. The company was incorporated in 1998 and is headquartered in Vernon Hills, Illinois.",9,"{'maxAge': 1, 'name': 'Mr. David A. Henninger M.S., R.A.C.', 'title': 'VP of Operations', 'exercisedValue': 0, 'unexercisedValue': 0}",1262217600,86400,4,0.09,0.09,0.09,0.09,0.09,0.09,0.09,0.09,-863.46936,2949,2949,1584,1584,1584,6966801,0.0003,0.294,5.0804095,0.01824,0.01824,0.0,0.0,USD,6289278,-1.70438,77408896,0.0,0.0,0.001,90.0,1262217600,1293753600,1269993600,-2337223,-0.035,1:8,1232064000,4.586,-2.615,PNK,EQUITY,WPHM,WPHM,WINSTON PHARMACEUTICALS INC,"Winston Pharmaceuticals, Inc.",1685971800,America/New_York,EDT,-14400000,0.09,none,677522,0.009,-2405335,0,0.948,1.044,1371307,0.021,-0.58621,-2.04601,-668346,-2714221,-3542726,-0.068,-0.3442,-1.75405,-1.76048,USD,
